106 related articles for article (PubMed ID: 31293658)
1. HCCR-1 is a Novel Prognostic Indicator for Gastric Cancer and Promotes Cell Proliferation.
Zhu LF; Ma P; Hu YL; Feng Y; Li P; Wang H; Guo YB; Mao QS; Xue WJ
J Cancer; 2019; 10(15):3533-3542. PubMed ID: 31293658
[TBL] [Abstract][Full Text] [Related]
2. Targeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3.
Zhang JL; Liu XZ; Wang PY; Chen GW; Jiang Y; Qiao SK; Zhu J; Wang X; Pan YS; Liu YC
Sci Rep; 2016 Apr; 6():24196. PubMed ID: 27052330
[TBL] [Abstract][Full Text] [Related]
3. Human cervical cancer oncogene-1 over expression in colon cancer and its clinical significance.
Meng K; Yuan M; Xu S; Wang L; Li Z; Wang M; Ma R
Int J Clin Exp Med; 2015; 8(1):939-43. PubMed ID: 25785079
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
5. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
6. [HCCR-2 enhances the division and proliferation of SMMC 7721 via PI3K/Akt pathway].
Yang YM; Qian JB; Hao B; Zhang GX
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):837-41. PubMed ID: 21138632
[TBL] [Abstract][Full Text] [Related]
7. HGF induces oncoprotein HCCR-1 expression through the Wnt/β-catenin pathway in gastric cancer.
Koh SA; Jung JY; Kim JR; Lee KH
Am J Transl Res; 2022; 14(3):1507-1517. PubMed ID: 35422931
[TBL] [Abstract][Full Text] [Related]
8. The HCCR oncoprotein as a biomarker for human breast cancer.
Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
[TBL] [Abstract][Full Text] [Related]
9. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
10. HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.
Ha SA; Kim HK; Yoo JA; Kim S; Shin SM; Gong GH; Lee YK; Kim JW
Mol Carcinog; 2014 Jan; 53(1):30-7. PubMed ID: 22851403
[TBL] [Abstract][Full Text] [Related]
11. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.
Xu LP; Qiu HB; Yuan SQ; Chen YM; Zhou ZW; Chen YB
J Cancer; 2020; 11(9):2708-2715. PubMed ID: 32201541
[No Abstract] [Full Text] [Related]
13. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.
Cho GW; Shin SM; Namkoong H; Kim HK; Ha SA; Hur SY; Kim TE; Chai YG; Kim JW
Gene; 2006 Dec; 384():18-26. PubMed ID: 16949218
[TBL] [Abstract][Full Text] [Related]
14. HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
Shin SM; Chung YJ; Oh ST; Jeon HM; Hwang LJ; Namkoong H; Kim HK; Cho GW; Hur SY; Kim TE; Lee YS; Park YG; Ko J; Kim JW
Gastroenterology; 2006 Jun; 130(7):2074-86. PubMed ID: 16762630
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
Wang K; Li J
Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
[TBL] [Abstract][Full Text] [Related]
17. Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity.
Ha SA; Shin SM; Kim HK; Kim S; Namkoong H; Lee YS; Kim HJ; Jung SM; Lee YS; Chung YJ; Park YG; Jung SS; Kim JW
J Cell Mol Med; 2009 Sep; 13(9B):3868-75. PubMed ID: 20196787
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and characterization of monoclonal antibody against HCCR protein].
Liu BC; Huo JR; Liu YF; Fan GC; Wang QM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1094-7. PubMed ID: 21968311
[TBL] [Abstract][Full Text] [Related]
19. Interaction of HCCR-1 and Bax in breast cancer.
Meng K; Yuan G; Bao H; Wang L; Ma R; Yu B; Zhao S
J BUON; 2019; 24(3):1027-1037. PubMed ID: 31424657
[TBL] [Abstract][Full Text] [Related]
20. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
